GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
16.00
+0.07 (0.44%)
At close: Mar 9, 2026, 4:00 PM EDT
15.98
-0.02 (-0.12%)
After-hours: Mar 9, 2026, 4:00 PM EDT
GH Research Employees
GH Research had 50 employees as of December 31, 2024. The number of employees increased by 1 or 2.04% compared to the previous year.
Employees
50
Change (1Y)
1
Growth (1Y)
2.04%
Revenue / Employee
n/a
Profits / Employee
-$965,160
Market Cap
992.47M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 50 | 1 | 2.04% |
| Dec 31, 2023 | 49 | 17 | 53.13% |
| Dec 31, 2022 | 32 | 18 | 128.57% |
| Dec 31, 2021 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| AbCellera Biologics | 596 |
| Pharming Group | 404 |
| Xeris Biopharma Holdings | 394 |
| UroGen Pharma | 287 |
| Geron | 229 |
| Inhibrx Biosciences | 161 |
| Cullinan Therapeutics | 111 |
| ArriVent BioPharma | 52 |
GHRS News
- 4 days ago - GH Research Reports Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - FDA Lifts Hold On GH Research's Depression Drug Trial After Two Years - Benzinga
- 2 months ago - GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026 - GlobeNewsWire
- 2 months ago - GH Research: GH001 Shows Robust Data Ahead Of FDA IND Decision - Seeking Alpha
- 2 months ago - GH Research to Announce IND Status for GH001 - GlobeNewsWire
- 4 months ago - GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 5 months ago - Depression-Focused GH Research Shares Could See Significant Upside: Analyst - Benzinga
- 5 months ago - GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress - GlobeNewsWire